Loading…
Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies
Context: The relationship between rising body mass index (BMI) and prospective risk of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is virtually absent. Objective: Determine the extent of the association between BMI and risk of future NAFLD diagnosis, stratifying by s...
Saved in:
Published in: | The journal of clinical endocrinology and metabolism 2016-03, Vol.101 (3), p.945-952 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4734-c56667541bd5f083ab59593fef54167f62c85ded663994b6b770c26a7a4168843 |
---|---|
cites | cdi_FETCH-LOGICAL-c4734-c56667541bd5f083ab59593fef54167f62c85ded663994b6b770c26a7a4168843 |
container_end_page | 952 |
container_issue | 3 |
container_start_page | 945 |
container_title | The journal of clinical endocrinology and metabolism |
container_volume | 101 |
creator | Loomis, A. Katrina Kabadi, Shaum Preiss, David Hyde, Craig Bonato, Vinicius St. Louis, Matthew Desai, Jigar Gill, Jason M. R Welsh, Paul Waterworth, Dawn Sattar, Naveed |
description | Context:
The relationship between rising body mass index (BMI) and prospective risk of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is virtually absent.
Objective:
Determine the extent of the association between BMI and risk of future NAFLD diagnosis, stratifying by sex and diabetes.
Design:
Two prospective studies using Humedica and Health Improvement Network (THIN) with 1.54 and 4.96 years of follow-up, respectively.
Setting:
Electronic health record databases.
Participants:
Patients with a recorded BMI measurement between 15 and 60 kg/m2, and smoking status, and 1 year of active status before baseline BMI. Patients with a diagnosis or history of chronic diseases were excluded.
Interventions:
None.
Main Outcome Measure:
Recorded diagnosis of NAFLD/NASH during follow-up (Humedica International Classification of Diseases, Ninth Revision code 571.8, and read codes for NAFLD and NASH in THIN).
Results:
Hazard ratios (HRs) were calculated across BMI categories using BMI of 20–22.5 kg/m2 as the reference category, adjusting for age, sex, and smoking status. Risk of recorded NAFLD/NASH increased linearly with BMI and was approximately 5-fold higher in Humedica (HR = 4.78; 95% confidence interval, 4.17–5.47) and 9-fold higher in THIN (HR = 8.93; 7.11–11.23) at a BMI of 30–32.5 kg/m2 rising to around 10-fold higher in Humedica (HR = 9.80; 8.49–11.32) and 14-fold higher in THIN (HR = 14.32; 11.04–18.57) in the 37.5- to 40-kg/m2 BMI category. Risk of NAFLD/NASH was approximately 50% higher in men and approximately double in those with diabetes.
Conclusions:
These data quantify the consistent and strong relationships between BMI and prospectively recorded diagnoses of NAFLD/NASH and emphasize the importance of weight reduction strategies for prevention and management of NAFLD. |
doi_str_mv | 10.1210/jc.2015-3444 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4803162</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1770883790</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4734-c56667541bd5f083ab59593fef54167f62c85ded663994b6b770c26a7a4168843</originalsourceid><addsrcrecordid>eNptkctvEzEQxi0Eomnhxhn5yIEtfq29ywEJ-qCVwkOlSNwsrz1LnG7sYO825L_HIaUCCUuWZc9vvpnxh9AzSo4po-TV0h4zQuuKCyEeoBltRV0p2qqHaEYIo1Wr2LcDdJjzkhAqRM0fowMmpWKStzMU3kW3xR9MzvgyOPiJTXD4yucbHHv8MQYz2LiIg7f43IzjFs_9LSR86jOYDK_x9SbiswHsmGIozAWYYVzgK7AxOfw5xbwusZKCv4yT85CfoEe9GTI8vTuP0Nfzs-uTi2r-6f3lydt5ZYXiorK1LB3Wgnau7knDTVe3dct76MubVL1ktqkdOFlmaEUnO6WIZdIoU8JNI_gRerPXXU_dCpyFMCYz6HXyK5O2Ohqv_40Ev9Df460WDeFUsiLw4k4gxR8T5FGvfLYwDCZAnLKmpWLTcNWSgr7co7bMmxP092Uo0TuL9NLqnUV6Z1HBn__d2j38x5MCiD2wicMIKd8M0waSXvz-W03KElI1VVGUhJdbVTbb6fJ9GgQXbfIB1gly1ss4pWJj_n83vwACw61t</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1770883790</pqid></control><display><type>article</type><title>Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies</title><source>Oxford Journals Online</source><creator>Loomis, A. Katrina ; Kabadi, Shaum ; Preiss, David ; Hyde, Craig ; Bonato, Vinicius ; St. Louis, Matthew ; Desai, Jigar ; Gill, Jason M. R ; Welsh, Paul ; Waterworth, Dawn ; Sattar, Naveed</creator><creatorcontrib>Loomis, A. Katrina ; Kabadi, Shaum ; Preiss, David ; Hyde, Craig ; Bonato, Vinicius ; St. Louis, Matthew ; Desai, Jigar ; Gill, Jason M. R ; Welsh, Paul ; Waterworth, Dawn ; Sattar, Naveed</creatorcontrib><description>Context:
The relationship between rising body mass index (BMI) and prospective risk of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is virtually absent.
Objective:
Determine the extent of the association between BMI and risk of future NAFLD diagnosis, stratifying by sex and diabetes.
Design:
Two prospective studies using Humedica and Health Improvement Network (THIN) with 1.54 and 4.96 years of follow-up, respectively.
Setting:
Electronic health record databases.
Participants:
Patients with a recorded BMI measurement between 15 and 60 kg/m2, and smoking status, and 1 year of active status before baseline BMI. Patients with a diagnosis or history of chronic diseases were excluded.
Interventions:
None.
Main Outcome Measure:
Recorded diagnosis of NAFLD/NASH during follow-up (Humedica International Classification of Diseases, Ninth Revision code 571.8, and read codes for NAFLD and NASH in THIN).
Results:
Hazard ratios (HRs) were calculated across BMI categories using BMI of 20–22.5 kg/m2 as the reference category, adjusting for age, sex, and smoking status. Risk of recorded NAFLD/NASH increased linearly with BMI and was approximately 5-fold higher in Humedica (HR = 4.78; 95% confidence interval, 4.17–5.47) and 9-fold higher in THIN (HR = 8.93; 7.11–11.23) at a BMI of 30–32.5 kg/m2 rising to around 10-fold higher in Humedica (HR = 9.80; 8.49–11.32) and 14-fold higher in THIN (HR = 14.32; 11.04–18.57) in the 37.5- to 40-kg/m2 BMI category. Risk of NAFLD/NASH was approximately 50% higher in men and approximately double in those with diabetes.
Conclusions:
These data quantify the consistent and strong relationships between BMI and prospectively recorded diagnoses of NAFLD/NASH and emphasize the importance of weight reduction strategies for prevention and management of NAFLD.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.2015-3444</identifier><identifier>PMID: 26672639</identifier><language>eng</language><publisher>United States: Endocrine Society</publisher><subject>Adult ; Body Mass Index ; Diabetes Complications - epidemiology ; Electronic Health Records ; Female ; Humans ; Male ; Middle Aged ; Non-alcoholic Fatty Liver Disease - epidemiology ; Original ; Prospective Studies ; Risk Factors ; Sex Factors ; Smoking - epidemiology</subject><ispartof>The journal of clinical endocrinology and metabolism, 2016-03, Vol.101 (3), p.945-952</ispartof><rights>Copyright © 2016 by the Endocrine Society</rights><rights>Copyright © 2016 by The Endocrine Society</rights><rights>Copyright © 2016 by the Endocrine Society 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4734-c56667541bd5f083ab59593fef54167f62c85ded663994b6b770c26a7a4168843</citedby><cites>FETCH-LOGICAL-c4734-c56667541bd5f083ab59593fef54167f62c85ded663994b6b770c26a7a4168843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26672639$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Loomis, A. Katrina</creatorcontrib><creatorcontrib>Kabadi, Shaum</creatorcontrib><creatorcontrib>Preiss, David</creatorcontrib><creatorcontrib>Hyde, Craig</creatorcontrib><creatorcontrib>Bonato, Vinicius</creatorcontrib><creatorcontrib>St. Louis, Matthew</creatorcontrib><creatorcontrib>Desai, Jigar</creatorcontrib><creatorcontrib>Gill, Jason M. R</creatorcontrib><creatorcontrib>Welsh, Paul</creatorcontrib><creatorcontrib>Waterworth, Dawn</creatorcontrib><creatorcontrib>Sattar, Naveed</creatorcontrib><title>Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Context:
The relationship between rising body mass index (BMI) and prospective risk of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is virtually absent.
Objective:
Determine the extent of the association between BMI and risk of future NAFLD diagnosis, stratifying by sex and diabetes.
Design:
Two prospective studies using Humedica and Health Improvement Network (THIN) with 1.54 and 4.96 years of follow-up, respectively.
Setting:
Electronic health record databases.
Participants:
Patients with a recorded BMI measurement between 15 and 60 kg/m2, and smoking status, and 1 year of active status before baseline BMI. Patients with a diagnosis or history of chronic diseases were excluded.
Interventions:
None.
Main Outcome Measure:
Recorded diagnosis of NAFLD/NASH during follow-up (Humedica International Classification of Diseases, Ninth Revision code 571.8, and read codes for NAFLD and NASH in THIN).
Results:
Hazard ratios (HRs) were calculated across BMI categories using BMI of 20–22.5 kg/m2 as the reference category, adjusting for age, sex, and smoking status. Risk of recorded NAFLD/NASH increased linearly with BMI and was approximately 5-fold higher in Humedica (HR = 4.78; 95% confidence interval, 4.17–5.47) and 9-fold higher in THIN (HR = 8.93; 7.11–11.23) at a BMI of 30–32.5 kg/m2 rising to around 10-fold higher in Humedica (HR = 9.80; 8.49–11.32) and 14-fold higher in THIN (HR = 14.32; 11.04–18.57) in the 37.5- to 40-kg/m2 BMI category. Risk of NAFLD/NASH was approximately 50% higher in men and approximately double in those with diabetes.
Conclusions:
These data quantify the consistent and strong relationships between BMI and prospectively recorded diagnoses of NAFLD/NASH and emphasize the importance of weight reduction strategies for prevention and management of NAFLD.</description><subject>Adult</subject><subject>Body Mass Index</subject><subject>Diabetes Complications - epidemiology</subject><subject>Electronic Health Records</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Non-alcoholic Fatty Liver Disease - epidemiology</subject><subject>Original</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>Sex Factors</subject><subject>Smoking - epidemiology</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNptkctvEzEQxi0Eomnhxhn5yIEtfq29ywEJ-qCVwkOlSNwsrz1LnG7sYO825L_HIaUCCUuWZc9vvpnxh9AzSo4po-TV0h4zQuuKCyEeoBltRV0p2qqHaEYIo1Wr2LcDdJjzkhAqRM0fowMmpWKStzMU3kW3xR9MzvgyOPiJTXD4yucbHHv8MQYz2LiIg7f43IzjFs_9LSR86jOYDK_x9SbiswHsmGIozAWYYVzgK7AxOfw5xbwusZKCv4yT85CfoEe9GTI8vTuP0Nfzs-uTi2r-6f3lydt5ZYXiorK1LB3Wgnau7knDTVe3dct76MubVL1ktqkdOFlmaEUnO6WIZdIoU8JNI_gRerPXXU_dCpyFMCYz6HXyK5O2Ohqv_40Ev9Df460WDeFUsiLw4k4gxR8T5FGvfLYwDCZAnLKmpWLTcNWSgr7co7bMmxP092Uo0TuL9NLqnUV6Z1HBn__d2j38x5MCiD2wicMIKd8M0waSXvz-W03KElI1VVGUhJdbVTbb6fJ9GgQXbfIB1gly1ss4pWJj_n83vwACw61t</recordid><startdate>201603</startdate><enddate>201603</enddate><creator>Loomis, A. Katrina</creator><creator>Kabadi, Shaum</creator><creator>Preiss, David</creator><creator>Hyde, Craig</creator><creator>Bonato, Vinicius</creator><creator>St. Louis, Matthew</creator><creator>Desai, Jigar</creator><creator>Gill, Jason M. R</creator><creator>Welsh, Paul</creator><creator>Waterworth, Dawn</creator><creator>Sattar, Naveed</creator><general>Endocrine Society</general><general>Copyright by The Endocrine Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201603</creationdate><title>Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies</title><author>Loomis, A. Katrina ; Kabadi, Shaum ; Preiss, David ; Hyde, Craig ; Bonato, Vinicius ; St. Louis, Matthew ; Desai, Jigar ; Gill, Jason M. R ; Welsh, Paul ; Waterworth, Dawn ; Sattar, Naveed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4734-c56667541bd5f083ab59593fef54167f62c85ded663994b6b770c26a7a4168843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Body Mass Index</topic><topic>Diabetes Complications - epidemiology</topic><topic>Electronic Health Records</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Non-alcoholic Fatty Liver Disease - epidemiology</topic><topic>Original</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>Sex Factors</topic><topic>Smoking - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Loomis, A. Katrina</creatorcontrib><creatorcontrib>Kabadi, Shaum</creatorcontrib><creatorcontrib>Preiss, David</creatorcontrib><creatorcontrib>Hyde, Craig</creatorcontrib><creatorcontrib>Bonato, Vinicius</creatorcontrib><creatorcontrib>St. Louis, Matthew</creatorcontrib><creatorcontrib>Desai, Jigar</creatorcontrib><creatorcontrib>Gill, Jason M. R</creatorcontrib><creatorcontrib>Welsh, Paul</creatorcontrib><creatorcontrib>Waterworth, Dawn</creatorcontrib><creatorcontrib>Sattar, Naveed</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Loomis, A. Katrina</au><au>Kabadi, Shaum</au><au>Preiss, David</au><au>Hyde, Craig</au><au>Bonato, Vinicius</au><au>St. Louis, Matthew</au><au>Desai, Jigar</au><au>Gill, Jason M. R</au><au>Welsh, Paul</au><au>Waterworth, Dawn</au><au>Sattar, Naveed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2016-03</date><risdate>2016</risdate><volume>101</volume><issue>3</issue><spage>945</spage><epage>952</epage><pages>945-952</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><abstract>Context:
The relationship between rising body mass index (BMI) and prospective risk of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is virtually absent.
Objective:
Determine the extent of the association between BMI and risk of future NAFLD diagnosis, stratifying by sex and diabetes.
Design:
Two prospective studies using Humedica and Health Improvement Network (THIN) with 1.54 and 4.96 years of follow-up, respectively.
Setting:
Electronic health record databases.
Participants:
Patients with a recorded BMI measurement between 15 and 60 kg/m2, and smoking status, and 1 year of active status before baseline BMI. Patients with a diagnosis or history of chronic diseases were excluded.
Interventions:
None.
Main Outcome Measure:
Recorded diagnosis of NAFLD/NASH during follow-up (Humedica International Classification of Diseases, Ninth Revision code 571.8, and read codes for NAFLD and NASH in THIN).
Results:
Hazard ratios (HRs) were calculated across BMI categories using BMI of 20–22.5 kg/m2 as the reference category, adjusting for age, sex, and smoking status. Risk of recorded NAFLD/NASH increased linearly with BMI and was approximately 5-fold higher in Humedica (HR = 4.78; 95% confidence interval, 4.17–5.47) and 9-fold higher in THIN (HR = 8.93; 7.11–11.23) at a BMI of 30–32.5 kg/m2 rising to around 10-fold higher in Humedica (HR = 9.80; 8.49–11.32) and 14-fold higher in THIN (HR = 14.32; 11.04–18.57) in the 37.5- to 40-kg/m2 BMI category. Risk of NAFLD/NASH was approximately 50% higher in men and approximately double in those with diabetes.
Conclusions:
These data quantify the consistent and strong relationships between BMI and prospectively recorded diagnoses of NAFLD/NASH and emphasize the importance of weight reduction strategies for prevention and management of NAFLD.</abstract><cop>United States</cop><pub>Endocrine Society</pub><pmid>26672639</pmid><doi>10.1210/jc.2015-3444</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-972X |
ispartof | The journal of clinical endocrinology and metabolism, 2016-03, Vol.101 (3), p.945-952 |
issn | 0021-972X 1945-7197 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4803162 |
source | Oxford Journals Online |
subjects | Adult Body Mass Index Diabetes Complications - epidemiology Electronic Health Records Female Humans Male Middle Aged Non-alcoholic Fatty Liver Disease - epidemiology Original Prospective Studies Risk Factors Sex Factors Smoking - epidemiology |
title | Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T13%3A39%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Body%20Mass%20Index%20and%20Risk%20of%20Nonalcoholic%20Fatty%20Liver%20Disease:%20Two%20Electronic%20Health%20Record%20Prospective%20Studies&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Loomis,%20A.%20Katrina&rft.date=2016-03&rft.volume=101&rft.issue=3&rft.spage=945&rft.epage=952&rft.pages=945-952&rft.issn=0021-972X&rft.eissn=1945-7197&rft_id=info:doi/10.1210/jc.2015-3444&rft_dat=%3Cproquest_pubme%3E1770883790%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4734-c56667541bd5f083ab59593fef54167f62c85ded663994b6b770c26a7a4168843%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1770883790&rft_id=info:pmid/26672639&rfr_iscdi=true |